Research
Hormonal
Specific natural compounds, such as resveratrol, curcumin, and honey, improve glucose control and insulin sensitivity through mechanisms like activating sirtuins, inhibiting alpha-amylase, and reducing oxidative stress in pancreatic beta-cells.
Consider adding foods rich in resveratrol (grapes, berries), curcumin (turmeric), and honey to your diet. These natural compounds can help protect pancreatic beta-cells, improve insulin sensitivity, and reduce inflammation, contributing to better glucose control.
ModerateSupportsMEDIUM confidence
Resveratrol... enhances insulin sensitivity by activation of deacetylases sirtuins 1–7, protects β-cells from oxidative stress, interacts with PPARγ receptor. Curcumin... supports pancreatic cell viability by inhibition of lipid peroxidation, NF-κB activation and reduction of inflammatory cytokine levels. Honey... hypoglycaemic properties are attributed to several mechanisms, the most important mechanism is based on fructose action... Honey has antioxidant properties and reduces oxidative stress in pancreatic β-cells.
Why this rating
Based on a review of various studies, including in vitro and animal models, with some human trials.
Source
Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus
Jana Bláhová et al. · Pharmaceuticals · 2021
DOI 10.3390/ph14080806
narrative_reviewCited 274×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Natural therapeutic products, including non-flavonoid polyphenols, flavonoids, and specific plant-derived foods, serve as safer alternatives or synergistic combination therapies for Type 2 Diabetes Mellitus (T2DM) by improving insulin sensitivity, reducing oxidative stress, and ameliorating complications with fewer side effects than synthetic pharmaceuticals.Moderate
- Pharmaceutical drugs for T2DM, while effective, are associated with harmful side effects, making natural therapeutic products a preferred option for prevention and early-stage management.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →